The cardiovascular outcomes data are not expected to be available in time for an initial NDA filing, which is consistent with regulatory precedent: the FDA can approve an obesity agent based on weight and safety data, then require post-marketing cardiovascular outcome data as a condition of approval
Always talk with your prescriber about your own situation before making decisions about drinking on any medication
Rotating injection sites helps prevent injection site reactions, like bruising, redness, or mild pain
Joao A, Reis F, Fernandes R
Si existe dolor intenso, vmitos, distensin marcada o varios das sin evacuar, no conviene seguir aumentando salvado por cuenta propia